Vaccine potency drops in the elderly and little is known about why this happens. Now, European scientists are on a mission to understand waning immunity and to develop strategies that make vaccines work effectively in all ...
May 17, 2022
0
5
Emotions are tricky things. They allow for humans to fall in love, wage war and, as it turns out, engage in self-harm.
Apr 29, 2022
0
20
It's no mystery why online games became an even-more popular pastime during the COVID-19 pandemic: They provide entertainment and social connection, while also keeping our brains stimulated. A new AI-powered game developed ...
Apr 28, 2022
0
2
Age-related changes in strength and mobility may depend on genetic variations in a critical mitochondrial enzyme, suggests a study published today in eLife.
Apr 26, 2022
0
8
As states have legalized marijuana for medicinal and recreational use, and federal law now allows sale of hemp-derived products,cannabis and its derivatives are getting more attention and study. The Conversation has compiled ...
Apr 20, 2022
0
6
A research group led by Kazunobu Sawamoto, a professor at Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences and National Institute for Physiological Sciences, and Chihiro Kurematsu, a ...
Mar 17, 2022
0
24
Fusing human retinal cells with adult stem cells could be a potential therapeutic strategy to treat retinal damage and visual impairment, according to the findings of a new study published in the journal eBioMedicine. The ...
Mar 15, 2022
0
46
Not too long ago, the idea of taking—for instance—a skin cell and transforming it into a muscle cell was unthinkable. About 10 years ago, however, revolutionary research showed that it is indeed possible to reprogram ...
Jan 6, 2022
0
142
Teenagers and young adults who turn to TikTok for sexual education may be vulnerable to misinformation, according to an article co-authored by University of Houston Law Center Research Assistant Professor Leah Fowler of the ...
Dec 22, 2021
0
13
US biotech company Moderna on Friday announced promising data from an early-stage human trial of its mRNA flu shot, based on the same technology used in its successful COVID-19 vaccine.
Dec 10, 2021
0
37
